Cysticidal effect on Acanthamoeba and toxicity on human keratocytes by polyhexamethylene biguanide and chlorhexidine

Cornea

Volumn 26, Issue 6, 2007, Pages 736-741

  Lee, Ji Eun ^a   Oum, Boo Sup ^a   Choi, Hee Young ^a   Yu, Hak Sun ^a   Lee, Jong Soo ^a,b  

^a Pusan National University Hospital   (South Korea)

^b Pusan National University School of Medicine   (South Korea)

Author keywords

Acanthamoeba; Chlorhexidine; Human corneal keratocyte; Minimal cysticidal concentration; Polyhexamethylene biguanide

Indexed keywords

ABRACIL; BAQUACIL; CHLORHEXIDINE; DISINFECTANT AGENT; POLY(HEXAMETHYLENEBIGUANIDE); UNCLASSIFIED DRUG;

ACANTHAMOEBA; ARTICLE; CELL CULTURE; CELL SURVIVAL; CONTROLLED STUDY; CORNEA CELL; CYST; CYTOTOXICITY; DRUG EFFECT; DRUG EFFICACY; ELECTRON MICROSCOPY; HUMAN; HUMAN CELL; MORPHOLOGY; PHASE CONTRAST MICROSCOPY; PRIORITY JOURNAL; SAFETY; SURVIVAL RATE;

ACANTHAMOEBA CASTELLANII; AMEBICIDES; ANIMALS; BIGUANIDES; CELL SURVIVAL; CELLS, CULTURED; CHLORHEXIDINE; CORNEAL STROMA; DISINFECTANTS; FIBROBLASTS; HUMANS; MICROSCOPY, ELECTRON, TRANSMISSION; MICROSCOPY, PHASE-CONTRAST; PARASITIC SENSITIVITY TESTS;

EID: 34447527558     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICO.0b013e31805b7e8e     Document Type: Article

References (29)

1. Nagington J, Watson PG, Playfair TJ. Amoebic infection of the eye. Lancet. 1974;2:1537-1540.
2. Wilhelmus KR. Introduction of the increasing importance of Acanthamoeba. Rev Infect Dis. 1991;13:S367-S368.
3. Auran D, Starr MB, Jakobiec FA. Acanthamoeba keratitis: a review of the literature. Cornea. 1987;6:2-26.
4. Moore MB, McCulley JP, Luckenbach M, et al. Acanthamoeba keratitis associated with soft contact lenses. Am J Ophthalamol. 1985;100:396-403.
5. Hay J, Colin MK, David VS, et al. Drug resistance and Acanthamoeba keratitis: the quest for alternative antiprotozoal chemotherapy. Eye. 1994;8:555-563.
6. Tirado-Angel J, Gabriel MM, Wilson LA, et al. Effects of polyhexamethylene and chlorhexidine on four species of Acanthamoeba in vitro. Curr Eye Res. 1996;15:225-228.
7. Seal DV, Hay J, Kirkness CM. Chlorhexidine or polyhexamethylene biguanide for acanthamoeba keratitis. Lancet. 1995;345:136.
8. Kong HH, Shin JY, Yu HS, et al. Mitochondria DNA RFLP and 18s small subunit ribosomal DNA PCR-RFLP of Acanthamoeba isolated from contact lens storage cases of residents in southwestern Korea. J Clin Microbiol. 2002;40:1199-1206.
9. Lee SM, Choi YJ, Ryu HW, et al. Species identification and molecular characterization of Acanthamoeba isolated from contact lens paraphernalia. Korean J Ophthalmol. 1997;11:39-50.
10. Yu HS, Choi KH, Kim HK, et al. Genetic analysis of Acanthamoeba isolates from contact lens storage cases of students in Seoul, Korea. Korean J Parasitol. 2001;39:161-170.
11. Yu HS, Kong HH, Kim SY, et al. Labaratory investigation of Acanthamoeba lugdunesis from patients with keratitis. Invest Ophthalmol Vis Sci. 2004;45:1418-1426.
12. Chung DI, Yu HS, Hwang MY, et al. Subgenus classification of Acanthamoeba by riboprinting. Korean J Parasitol. 1998;36:69-80.
13. Gast RJ, LeDee D, Fuerst PA, et al. Subfenus systematics of Acanthamoeba: four nuclear 18S rDNA sequence types. J Eukaryot Microbiol. 1996;43:498-504.
14. Stothard DR, Schroeder-Diedrich M, Awwad MH, et al. The evolutionary history of genus Acanthamoeba and the identification of eight new 18S rRNA gene sequence types. J Eukaryot Microbiol. 1998;45:45-54.
15. Moore MB, McCulley JP, Luckenbach M. Acanthamoeba keratitis associated with soft contact lenses. Am J Ophthalmol. 1985;100:396-403.
16. Cohen EJ, Parlato CJ, Arentsen JJ, et al. Medical and surgical treatment of Acanthamoeba keratitis. Am J Ophthalmol. 1987;103:615-625.
17. Bacon AS, Frazer DG, Matheson M, et al. A review of 72 cases of Acanthamoeba keratitis. Eye. 1993;7:719-725.
18. Larkin DFP, Kilvington S, Dart JKG. Treatment of Acanthamoeba keratitis with polyhexamethylene biguanide. Ophthalmology. 1992;99:185-191.
19. Ikeda T, Ledwith A, Bamford CH, et al. Interaction of polymeric biguanide biocide with phospholipid membranes. Biochim Biophys Acta. 1983;769:57-66.
20. Ikeda T, Tazuke S, Watanabe M. Interaction of biologically active molecules with phospholipid membranes I. Fluorescence depolarization studies on the effect of polymeric biocide bearing biguanide groups in the main chain. Biochim Biophys Acta. 1984;735:380-386.
21. Deleted in proof.
22. Deleted in proof.
23. Seal DV, Hay J, Kirkness C, et al. Successful medical therapy of Acanathamoeba keratitis with topical chlorhexidine and propamidine. Eye. 1996;10:412-421.
24. Narasimhan S, Madhavan HN, K LT. Development and application of an in vitro susceptibility test for Acanthamoeba species isolated from keratitis to polyhexamethylene biguanide and chlorhexidine. Cornea. 2002;21:203-205.
25. Duguid IGM, Dart JKG, Morlet N, et al. Outcome of Acanthamoeba keratitis treated with polyhexamethylene biguanide and propamidine. Ophthalmology. 1997;104:1587-1592.
26. Green K, Livingston V, Bowman K, et al. Chlorhexidine effects on corneal epithelium and endothelium. Arch Ophthalmol. 1980;8:1273-1278.
27. Khunkitti W, Hann AC, Lloyd D, et al. Biguanide-induced changes in Acanthamoeba castellanii: an electron microscopic study. J Appl Microbiol. 1998;84:53-62.
28. Deleted in proof.
29. Mathers W. Use of higher medication concentrations in the treatment of acanthamoeba keratitis. Arch Ophthalmol. 2006;6:923